TY - JOUR
T1 - Use of nitric oxide-nucleophile adducts as biological sources of nitric oxide
T2 - Effects on airway smooth muscle
AU - Hirasaki, Akihito
AU - Jones, Keith A.
AU - Perkins, William J.
AU - Warner, David O.
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 1996/9
Y1 - 1996/9
N2 - Nitric oxide (NO)-nucleophile adducts are compounds of the general structure [XN(O)NO]-, where X is a nucleophile residue, and they release NO spontaneously in aqueous solution. This study determined the effects of two NO-nucleophile adducts [diethylaminodiazen-1-ium-1,2-diolate (DEA-NO) and sperminediazen-1-ium-1,2-diolate (spermine-NO)] on isometric force and the cytosolic concentrations of cyclic GMP ([cGMP]1), cyclic AMP ([cAMP]i) and calcium in canine tracheal smooth muscle. The ratio of fura-2 emission fluorescence intensities with excitation at 340- and 380-nm wavelengths (F340/F380) was used as an index of cytosolic [Ca++] concentration. Both DEA-NO and spermine-NO caused a concentration-dependent and reversible decrease in force (EC50 of 0.13 ± 0.02 μM and 4.1 ± 0.3 μM, respectively) and F340/F380, a concentration-dependent increase in [cGMP](i) and no change in [cAMP]i. There were no significant differences in the relationship between [cGMP](i) and the percentage decrease in force or in the relationship between the percentage decrease in F340/F380 and the percentage decrease in force between tissues relaxed with DEA-NO or spermine- NO. Oxyhemoglobin increased the EC50 for both DEA-NO (from 0.13 ± 0.03 μM to 8.1 ± 0.2 μM) and spermine-NO (from 3.9 ± 0.3 μM to 81.6 ± 6.4 μM) and completely scavenged NO released by 0.13 (EC50) and 1 (EC100) μM DEA-NO. These results suggest that both DEA-NO and spermine-NO generate NO extracellularly and relax airway smooth muscle in association with an increase in [cGMP](i) and a decrease in cytosolic Ca++ concentration. NO- nucleophile adducts may serve as vehicles for the controlled delivery of NO into biological systems and thus provide a useful tool by which the physiology of NO can be investigated.
AB - Nitric oxide (NO)-nucleophile adducts are compounds of the general structure [XN(O)NO]-, where X is a nucleophile residue, and they release NO spontaneously in aqueous solution. This study determined the effects of two NO-nucleophile adducts [diethylaminodiazen-1-ium-1,2-diolate (DEA-NO) and sperminediazen-1-ium-1,2-diolate (spermine-NO)] on isometric force and the cytosolic concentrations of cyclic GMP ([cGMP]1), cyclic AMP ([cAMP]i) and calcium in canine tracheal smooth muscle. The ratio of fura-2 emission fluorescence intensities with excitation at 340- and 380-nm wavelengths (F340/F380) was used as an index of cytosolic [Ca++] concentration. Both DEA-NO and spermine-NO caused a concentration-dependent and reversible decrease in force (EC50 of 0.13 ± 0.02 μM and 4.1 ± 0.3 μM, respectively) and F340/F380, a concentration-dependent increase in [cGMP](i) and no change in [cAMP]i. There were no significant differences in the relationship between [cGMP](i) and the percentage decrease in force or in the relationship between the percentage decrease in F340/F380 and the percentage decrease in force between tissues relaxed with DEA-NO or spermine- NO. Oxyhemoglobin increased the EC50 for both DEA-NO (from 0.13 ± 0.03 μM to 8.1 ± 0.2 μM) and spermine-NO (from 3.9 ± 0.3 μM to 81.6 ± 6.4 μM) and completely scavenged NO released by 0.13 (EC50) and 1 (EC100) μM DEA-NO. These results suggest that both DEA-NO and spermine-NO generate NO extracellularly and relax airway smooth muscle in association with an increase in [cGMP](i) and a decrease in cytosolic Ca++ concentration. NO- nucleophile adducts may serve as vehicles for the controlled delivery of NO into biological systems and thus provide a useful tool by which the physiology of NO can be investigated.
UR - http://www.scopus.com/inward/record.url?scp=0030434486&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030434486&partnerID=8YFLogxK
M3 - Article
C2 - 8819511
AN - SCOPUS:0030434486
SN - 0022-3565
VL - 278
SP - 1269
EP - 1275
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 3
ER -